Legal & General Group’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.2K | Sell |
4,087
-32,351
| -89% | -$310K | ﹤0.01% | 2759 |
|
|
2025
Q1 | $229K | Hold |
36,438
| – | – | ﹤0.01% | 2591 |
|
|
2024
Q4 | $296K | Buy |
36,438
+2,060
| +6% | +$16.7K | ﹤0.01% | 2607 |
|
|
2024
Q3 | $622K | Buy |
34,378
+53
| +0.2% | +$958 | ﹤0.01% | 2387 |
|
|
2024
Q2 | $354K | Buy |
34,325
+223
| +0.7% | +$2.3K | ﹤0.01% | 2543 |
|
|
2024
Q1 | $362K | Sell |
34,102
-151
| -0.4% | -$1.6K | ﹤0.01% | 2550 |
|
|
2023
Q4 | $313K | Buy |
34,253
+251
| +0.7% | +$2.29K | ﹤0.01% | 2614 |
|
|
2023
Q3 | $353K | Buy |
34,002
+1,726
| +5% | +$17.9K | ﹤0.01% | 2565 |
|
|
2023
Q2 | $462K | Buy |
32,276
+28,358
| +724% | +$406K | ﹤0.01% | 2488 |
|
|
2023
Q1 | $28K | Sell |
3,918
-3,503
| -47% | -$25K | ﹤0.01% | 2978 |
|
|
2022
Q4 | $83.3K | Hold |
7,421
| – | – | ﹤0.01% | 2857 |
|
|
2022
Q3 | $82K | Buy |
7,421
+1,093
| +17% | +$12.1K | ﹤0.01% | 2870 |
|
|
2022
Q2 | $54K | Buy |
6,328
+1,061
| +20% | +$9.05K | ﹤0.01% | 2993 |
|
|
2022
Q1 | $72K | Buy |
5,267
+89
| +2% | +$1.22K | ﹤0.01% | 2935 |
|
|
2021
Q4 | $102K | Hold |
5,178
| – | – | ﹤0.01% | 2904 |
|
|
2021
Q3 | $167K | Buy |
5,178
+2,739
| +112% | +$88.3K | ﹤0.01% | 2737 |
|
|
2021
Q2 | $82K | Buy |
2,439
+888
| +57% | +$29.9K | ﹤0.01% | 2797 |
|
|
2021
Q1 | $58K | Sell |
1,551
-72
| -4% | -$2.69K | ﹤0.01% | 2775 |
|
|
2020
Q4 | $54K | Buy |
1,623
+300
| +23% | +$9.98K | ﹤0.01% | 2777 |
|
|
2020
Q3 | $49K | Sell |
1,323
-489
| -27% | -$18.1K | ﹤0.01% | 2702 |
|
|
2020
Q2 | $60K | Buy |
1,812
+196
| +12% | +$6.49K | ﹤0.01% | 2681 |
|
|
2020
Q1 | $42K | Sell |
1,616
-501
| -24% | -$13K | ﹤0.01% | 2657 |
|
|
2019
Q4 | $66K | Buy |
+2,117
| New | +$66K | ﹤0.01% | 2717 |
|